Investment ThemesDetailed Quotes
Weight Loss Drugs
Watchlist
GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1548.903
- -18.203-1.16%
Close Jan 31 16:00 ET
1570.818High1548.537Low
1563.633Open1567.106Pre Close56.68MVolume1Rise57.03P/E (Static)4.90BTurnover--Flatline0.54%Turnover Ratio1.45TMarket Cap6Fall1.35TFloat Cap
Constituent Stocks: 7Top Rising: AMGN+0.49%
Sign in to post a comment
$Pfizer (PFE.US)$ cannot pass 27
1
$Viking Therapeutics (VKTX.US)$ see what ER bring.
1
$Pfizer (PFE.US)$ RFK is gonna sue all these bloody company
5
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Eli Lilly and Co (LLY.US)$ why is everyone bearish here, you all realise trump’s policy will increase prices of medicine?
1
4
$Novo-Nordisk A/S (NVO.US)$ competitors are already blewing substitutional drugs. Competitive advantages are disappearing the month it's new drugs are out. Seriously ?!
$Omega Healthcare Investors Inc (OHI.US)$ $Microsoft (MSFT.US)$
$Omega Healthcare Investors Inc (OHI.US)$ $Microsoft (MSFT.US)$
4
No comment yet
冰冰小 : The Earnings Reports will be released next week, aiming for 29.